Document

SD 1 formsd-2025conflictminerals.htm SD Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM SD

Specialized Disclosure Report

Medtronic plc

(Exact name of Registrant as Specified in its Charter)

Ireland

1-36820

98-1183488

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)


Building Two, Parkmore Business Park
West						n/a
Galway, Ireland
(Address of principal executive offices)						(Zip Code)



Thierry Piéton						763-514-4000

(Name and telephone number, including area code, of the person to contact in connection with this report.)

Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

xRule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2025.

Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended April 24, 2026.

INFORMATION TO BE INCLUDED IN THE REPORT

Section 1 - Conflict Minerals Disclosure

Item 1.01 Conflict Minerals Disclosure and Report

This Form SD of Medtronic plc (the “Company”) is filed pursuant to Rule 13p-1 (the “Rule”) promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period from January 1, 2025 to December 31, 2025

A copy of Company’s Conflict Minerals Report is provided as Exhibit 1.01 hereto and details the due diligence measures undertaken during the reporting period by the Company on a consolidated basis. A copy of the Conflict Minerals Report is also publicly available through the Company’s website by clicking the SEC Filings link under the Financials drop-down at www.investorrelations.medtronic.com.

Item 1.02 Exhibit

The Company has filed, as an exhibit to this Form SD, the Conflict Minerals Report of the Company required by Item 1.01.

Section 2 - Exhibits

Item 2.01 Exhibits

The following exhibit is filed as part of this report:

Exhibit 1.01 - Conflict Minerals Report of the Company

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.


		Medtronic plc
Date: May 28, 2026	By	/s/ Thierry Piéton
		Thierry Piéton
		Executive Vice President and Chief Financial Officer

EXHIBIT INDEX

Medtronic plc

Form SD


Exhibit No.	Description
1.01		Conflict Minerals Report of the Company